• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

LapBand


<



Watch out! I once interviewed for a Lapband position. During the interview, the manager, who is gay, brought his sexual orientation into the process. I could not care less about anyone's sexual orientation, but this was way out of line. I guess management doesn't care about what field manager's discuss or use as part of their decision process.
 












Similar threads